- Home
- SYRE vs SVM Comparison
SYRE vs SVM Comparison
Compare SYRE & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- SVM
- Stock Information
- Founded
- SYRE 2013
- SVM N/A
- Country
- SYRE United States
- SVM Canada
- Employees
- SYRE N/A
- SVM N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- SVM Precious Metals
- Sector
- SYRE Health Care
- SVM Basic Materials
- Exchange
- SYRE Nasdaq
- SVM Nasdaq
- Market Cap
- SYRE 1.1B
- SVM 1.1B
- IPO Year
- SYRE 2016
- SVM N/A
- Fundamental
- Price
- SYRE $16.26
- SVM $4.32
- Analyst Decision
- SYRE Buy
- SVM Strong Buy
- Analyst Count
- SYRE 5
- SVM 1
- Target Price
- SYRE $55.00
- SVM $6.75
- AVG Volume (30 Days)
- SYRE 545.5K
- SVM 5.6M
- Earning Date
- SYRE 08-06-2025
- SVM 08-07-2025
- Dividend Yield
- SYRE N/A
- SVM 0.58%
- EPS Growth
- SYRE N/A
- SVM 40.00
- EPS
- SYRE N/A
- SVM 0.28
- Revenue
- SYRE N/A
- SVM $298,895,000.00
- Revenue This Year
- SYRE N/A
- SVM $8.43
- Revenue Next Year
- SYRE N/A
- SVM $27.40
- P/E Ratio
- SYRE N/A
- SVM $15.43
- Revenue Growth
- SYRE N/A
- SVM 38.90
- 52 Week Low
- SYRE $10.91
- SVM $2.87
- 52 Week High
- SYRE $40.26
- SVM $5.32
- Technical
- Relative Strength Index (RSI)
- SYRE 48.34
- SVM 42.47
- Support Level
- SYRE $16.43
- SVM $4.26
- Resistance Level
- SYRE $17.70
- SVM $4.88
- Average True Range (ATR)
- SYRE 0.99
- SVM 0.20
- MACD
- SYRE -0.02
- SVM -0.07
- Stochastic Oscillator
- SYRE 37.17
- SVM 6.40
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.